As demonstrated in the Deficiency of Interleukin-1 Receptor antagonist (DIRA) syndrome, IL-1 antagonism is critical for the amelioration of IL-17-driven diseases. The gene discussed is IL1B; the disease is sterile multifocal osteomyelitis with periostitis and pustulosis.